Released: June 24, 2016
Defense Health Program
Parkinson's Research Program
Funding Opportunities for Fiscal Year 2016
The FY16 Defense Appropriations Act provides $16 million (M) to the Department of Defense Parkinson's Research Program (PRP), formerly the Neurotoxin Exposure Treatment Parkinson's Research Program (NETPRP), to support research of exceptional scientific merit leading to an understanding of the cause, prevention, and treatment of the loss of dopaminergic neurons in the substantia nigra that result in Parkinson's disease. Applications to the FY16 PRP are being solicited by the U.S. Army Medical Research Acquisition Activity (USAMRAA). The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP).
The PRP is providing the information in this pre-announcement to allow investigators time to plan and develop applications. FY16 PRP Program Announcements and General Application Instructions for the following award mechanisms are anticipated to be posted on the Grants.gov website in July 2016. Pre-application and application deadlines will be available when the Program Announcements are released. This pre-announcement should not be construed as an obligation by the government.
IMPORTANT: The PRP seeks to focus applications and direct funding by providing Focus Areas to address the critical needs in Parkinson's disease research. Applications must address at least one of the Focus Areas noted below:
- Studies of the neurovascular unit (including neurons, glia, the microvasculature, and the blood-brain barrier) in Parkinson's disease and changes associated with its treatment. (For both award mechanisms.)
- Identification and evaluation of mechanisms in early Parkinson's disease involving olfactory, microbiome, gastrointestinal, and/or autonomic nervous systems. (For both award mechanisms.)
- Mechanisms of neuroplasticity and compensation in Parkinson's disease, such as influences of sleep, exercise, and diet. (For both award mechanisms.)
- Underlying factors influencing the progression in Parkinson's disease in specific community-based populations (e.g., Veterans) to identify the heterogeneity of Parkinson's disease. (For Impact Award applications only.)
|Award Mechanism||Principal Investigator (PI) Eligibility||Key Mechanism Elements||Funding|
|Focused Idea Award||
Partnering PI Option:
A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions that will be available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all CDMRP funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.
Applications must be submitted through the federal government's single-entry portal, Grants.gov. Submission deadlines are not available until the Program Announcements are released. For email notification when Program Announcements are released go to the CDMRP website (https://cdmrp.army.mil) and select Subscribe to Funding Opportunities & Program Communications. For more information about the PRP or other CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.army.mil).
Point of Contact:
CDMRP Public Affairs